Literature DB >> 8857637

Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome.

P C Gerszten1, I F Pollack, A J Martínez, K H Lo, J Janosky, A L Albright.   

Abstract

The histopathology of 66 children with the diagnosis of ependymoma who were operated on at our institution between 1954 and 1994 were reviewed. We performed an initial analysis using the entire study cohort to determine which histopathological features associated with each other in a statistically significant fashion in an attempt to identify combinations of features that together might be useful in predicting outcome. A detailed outcome analysis was then performed on the 37 most recent cases who survived the postoperative period, in whom pre- and post-imaging studies as well as long term follow-up were obtained, in order to identify the histopathological features and combinations of features that were predictive of overall and progression-free survival. Five- and ten-year progression-free survivals were 45.1% and 36.1%, respectively. Overall survivals were 57.1% and 45.0%, respectively. Of the eight individual histopathological features, only the presence of necrosis was found to correlate with a less favorable overall and progression-free survival (PFS) (p = 0.06 and 0.03, respectively). In addition, the combination of necrosis with vascular proliferation or nuclear pleomorphism was associated with a worse PFS (p = 0.01 and 0.02, respectively). However, when other clinical predictive factors were included in a multivariate regression analysis, none of the histological features or combinations of features were independently associated with outcome. In addition, no relationship was found between the pattern of rosettes (true rosette, pseudorosette, or perivascular pseudorosette) and clinical outcome. In conclusion, although this study found an association between certain histopathological features and clinical outcome in children with ependymomas, these relationships did not reach statistical significance on multivariate analysis and, thus, do not provide sufficient evidence for modifying therapy based on histopathology alone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857637     DOI: 10.1016/s0344-0338(96)80100-2

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.

Authors:  David W Ellison; Mehmet Kocak; Dominique Figarella-Branger; Giangaspero Felice; Godfraind Catherine; Torsten Pietsch; Didier Frappaz; Maura Massimino; Jacques Grill; James M Boyett; Richard G Grundy
Journal:  J Negat Results Biomed       Date:  2011-05-31

2.  Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.

Authors:  A Korshunov; R Sycheva; V Timirgaz; A Golanov
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

3.  Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.

Authors:  Catherine Godfraind; Joanna M Kaczmarska; Mehmet Kocak; James Dalton; Karen D Wright; Robert A Sanford; Fredrick A Boop; Amar Gajjar; Thomas E Merchant; David W Ellison
Journal:  Acta Neuropathol       Date:  2012-04-21       Impact factor: 17.088

4.  A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.

Authors:  D M Ho; C Y Hsu; T T Wong; H Chiang
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

5.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

6.  Ependymoma in adults: surgery, reoperation and radiotherapy for survival.

Authors:  Dusan Vitanovics; Katalin Bálint; Zoltán Hanzély; Péter Banczerowski; Dénes Afra
Journal:  Pathol Oncol Res       Date:  2009-08-30       Impact factor: 3.201

7.  Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult.

Authors:  Masayuki Shintaku; Kenji Hashimoto
Journal:  Brain Tumor Pathol       Date:  2011-07-16       Impact factor: 3.298

8.  Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.

Authors:  M Carter; J Nicholson; F Ross; J Crolla; R Allibone; V Balaji; R Perry; D Walker; R Gilbertson; D W Ellison
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

9.  Infratentorial ependymomas--a study of the centre in Katowice.

Authors:  Marek Mandera; Joanna Makarska; Grażyna Sobol; Katarzyna Musioł
Journal:  Childs Nerv Syst       Date:  2015-03-31       Impact factor: 1.475

10.  Malignant Transformation of Grade II Ependymoma in a 2-Year-Old Child: Case Report.

Authors:  Şule Sarıkafa; Suat Erol Çelik; Enver Yarikkaya; Ayşe Sayılgan
Journal:  J Neurol Surg Rep       Date:  2015-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.